Eco R1 Capital, LLC Adaptimmune Therapeutics PLC Put Options Transaction History
Eco R1 Capital, LLC
- $1.27 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADAP
# of Institutions
75Shares Held
114MCall Options Held
77.5KPut Options Held
14.2K-
Long Focus Capital Management, LLC San Juan, PR23.8MShares$5.7 Million0.16% of portfolio
-
Two Seas Capital LP Rye, NY20.5MShares$4.93 Million0.15% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$4.1 Million0.32% of portfolio
-
Mpm Asset Management LLC Cambridge, MA5.34MShares$1.28 Million1.54% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.89MShares$1.17 Million0.18% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $39.2M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...